Retraction: AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation (PLoS ONE (2013) 8: 6 (e65556) DOI: 10.1371/journal.pone.0065556);AIB1 Cooperates with ERα to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Wang, Miao ^a   Zhao, Feng ^a   Li, Shujing ^a   Chang, Alan K ^a   Jia, Zhaojun ^a   Chen, Yixuan ^a   Xu, Feihong ^a   Pan, Hongming ^a   Wu, Huijian ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; ESTROGEN RECEPTOR ALPHA; NERVE CELL ADHESION MOLECULE; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR SNAI1; TRANSCRIPTION FACTOR SP1; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN;

AIB1 ONCOGENE; ARTICLE; BINDING SITE; BREAST CANCER; BREAST METASTASIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TUMOR INVASION;

EID: 84878813709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0252791     Document Type: Erratum

References (43)

1. DeSantis C, Siegel R, Bandi P, Jemal A, (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61: 409-418.
2. Welch DR, Steeg PS, Rinker-Schaeffer CW, (2000) Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2: 408-416.
3. Voulgari A, Pintzas A, (2009) Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 1796: 75-90.
4. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
5. Ross JS, Figge HL, Bui HX, del Rosario AD, Fisher HA, et al. (1994) E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome. Mod Pathol 7: 835-841.
6. Richmond PJ, Karayiannakis AJ, Nagafuchi A, Kaisary AV, Pignatelli M, (1997) Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res 57: 3189-3193.
7. de Herreros AG, Peiro S, Nassour M, Savagner P, (2010) Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 15: 135-147.
8. van Roy F, Berx G, (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788.
9. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, et al. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968.
10. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, et al. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580.
11. Li H, Gomes PJ, Chen JD, (1997) RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci U S A 94: 8479-8484.
12. Onate SA, Tsai SY, Tsai MJ, O'Malley BW, (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
13. Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW, (1997) TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem 272: 27629-27634.
14. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, et al. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677-684.
15. Xu J, Wu RC, O'Malley BW, (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615-630.
16. Alan KC, Huijian Wu, (2012) The role of AIB1 in breast cancer (Review). Oncology Letter 4: 588-594.
17. Mussi P, Yu C, O'Malley BW, Xu J, (2006) Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3. Mol Endocrinol 20: 3105-3119.
18. Louie MC, Zou JX, Rabinovich A, Chen HW, (2004) ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 24: 5157-5171.
19. Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, et al. (2006) Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66: 11039-11046.
20. Qin L, Liao L, Redmond A, Young L, Yuan Y, et al. (2008) The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 28: 5937-5950.
21. Li LB, Louie MC, Chen HW, Zou JX, (2008) Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression. Cancer Lett 261: 64-73.
22. Long W, Yi P, Amazit L, LaMarca HL, Ashcroft F, et al. (2010) SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration. Mol Cell 37: 321-332.
23. Lydon JP, O'Malley BW, (2011) Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology 152: 19-25.
24. Wu H, Sun L, Zhang Y, Chen Y, Shi B, et al. (2006) Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem 281: 21848-21856.
25. Li S, Yang C, Hong Y, Bi H, Zhao F, et al. (2012) The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 Ligase PIAS1. Biol Cell 104: 287-296.
26. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G, (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
27. Font de Mora J, Brown M, (2000) AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20: 5041-5047.
28. Nieto MA, (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166.
29. Torres-Arzayus MI, Font de Mora J, Yuan J, Vazquez F, Bronson R, et al. (2004) High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6: 263-274.
30. Bautista S, Valles H, Walker RL, Anzick S, Zeillinger R, et al. (1998) In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin Cancer Res 4: 2925-2929.
31. Wu H, Chen Y, Liang J, Shi B, Wu G, et al. (2005) Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438: 981-987.
32. Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, et al. (2006) N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 66: 3365-3369.
33. Peinado H, Olmeda D, Cano A, (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
34. Zhang H, Yi X, Sun X, Yin N, Shi B, et al. (2004) Differential gene regulation by the SRC family of coactivators. Genes Dev 18: 1753-1765.
35. Li S, Wang M, Ao X, Chang AK, Yang C, et al. (2012) CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-alpha. Oncogene: doi:10.1038/onc.2012.1518.
36. Wang M, Bao YL, Wu Y, Yu CL, Meng X, et al. (2008) Identification and characterization of the human testes-specific protease 50 gene promoter. DNA Cell Biol 27: 307-314.
37. Wang M, Bao YL, Wu Y, Yu CL, Meng XY, et al. (2010) Basic FGF downregulates TSP50 expression via the ERK/Sp1 pathway. J Cell Biochem 111: 75-81.
38. Hong Y, Xing X, Li S, Bi H, Yang C, et al. (2011) SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS One 6: e23046.
39. Yang C, Li S, Wang M, Chang AK, Liu Y, et al. (2013) PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha. Mol Cancer 12: 21.
40. Louie MC, Revenko AS, Zou JX, Yao J, Chen HW, (2006) Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Mol Cell Biol 26: 3810-3823.
41. Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, et al. (2011) Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab Invest 91: 1443-1458.
42. Shi B, Liang J, Yang X, Wang Y, Zhao Y, et al. (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 27: 5105-5119.
43. Zhou L, Bao YL, Zhang Y, Wu Y, Yu CL, et al. (2010) Knockdown of TSP50 inhibits cell proliferation and induces apoptosis in P19 cells. IUBMB Life 62: 825-832.